[ON MODIFICATIONS OF PLASMA AND URINARY ELECTROLYTES IN ASCITOGENIC HEPATIC CIRRHOSIS IN TREATMENT WITH TRIAMTERENE ALONE AND ASSOCIATED WITH HYDROCHLOROTHIAZIDE AND WITH SPIRONOLACTONE].
D001201:Ascites; D035843:Biomedical Research; D002712:Chlorides; D004573:Electrolytes; D005853:Geriatrics; D006801:Humans; D006852:Hydrochlorothiazide; D008103:Liver Cirrhosis; D010949:Plasma; D011188:Potassium; D012964:Sodium; D012982:Sodium, Dietary; D013148:Spironolactone; D014223:Triamterene; D014556:Urine; D014882:Water-Electrolyte Balance
D002712:Chlorides; D004573:Electrolytes; D012982:Sodium, Dietary; D006852:Hydrochlorothiazide; D013148:Spironolactone; D012964:Sodium; D011188:Potassium; D014223:Triamterene
ASCITES; CHLORIDES; CLINICAL RESEARCH; ELECTROLYTES; GERIATRICS; HYDROCHLOROTHIAZIDE; LIVER CIRRHOSIS; PLASMA; POTASSIUM; SODIUM; SPIRONOLACTONE; TRIAMTERENE; URINE; WATER-ELECTROLYTE BALANCE
SULLE MODIFICAZIONI DEGLI ELETTROLITI PLASMATICI E URINARI NELLE CIRROSI EPATICHE ASCITOGENE IN TRATTAMENTO CON TRIAMTERENE DA SOLO E ASSOCIATO CON IDROCLOROTIAZIDE E CON SPIRONOLATTONE.